|LETTER TO EDITOR
|Year : 2015 | Volume
| Issue : 1 | Page : 90
175Yb-TTHMP for bone pain palliation
Sim Sai Tin1, Viroj Wiwanitkit2
1 Medical Center, Shantou, China
2 Hainan Medical University, China
|Date of Web Publication||23-Dec-2014|
Porf. Sim Sai Tin
Medical Center, Shantou
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Tin SS, Wiwanitkit V. 175Yb-TTHMP for bone pain palliation. Indian J Nucl Med 2015;30:90
We would like to discuss on the publication on " 175 Yb-TTHMP for bone pain palliation."  Safarzadeh proposed " 175 Yb-TTHMP can be a good candidate for bone pain palliation and substitute of other radiopharmaceuticals."  The production of 175 Yb is the first consideration. Since preparation of 175 Yb requires specific standard atomic chemistry center, it might be limited prepared and distributed for actual clinical usage.  Second, since 175 Yb is rather limited study, its actual effect and adverse effect are still unknown. Dosage that can be problematic has never been clarified, and this is an issue for further studying.  Finally, to control of bone pain, not only finding the new palliative agent but also the good holistic care, including psychological support, is needed. 
| References|| |
Safarzadeh L. 175
Yb-TTHMP as a good candidate for bone pain palliation and substitute of other radiopharmaceuticals. Indian J Nucl Med 2014;29:135-9.
Chakraborty S, Unni PR, Venkatesh M, Pillai MR. Feasibility study for production of 175
Yb: A promising therapeutic radionuclide. Appl Radiat Isot 2002;57:295-301.
Kaurin DG, Baum JW, Carsten AL, Schaefer CW. Scab incidence on pig skin resulting from hot particle exposures under varying conditions. Health Phys 2001;81:47-56.
Barton MB, Dawson R, Jacob S, Currow D, Stevens G, Morgan G. Palliative radiotherapy of bone metastases: An evaluation of outcome measures. J Eval Clin Pract 2001;7:47-64.